Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients

Blood Pressure

Volumn 22, Issue 2, 2013, Pages 86-93

  Chillo, Pilly ^a,b   Rieck, Åshild E ^a   Lwakatare, Johnson ^b   Lutale, Janet ^b   Gerdts, Eva ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Diabetes mellitus; Left atrial volume; Left ventricular diastolic dysfunction; Sub Saharan Africa

Indexed keywords

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BODY SURFACE; CONTROLLED STUDY; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM ENLARGEMENT; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART VOLUME; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LEFT ATRIUM VOLUME INDEX; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MITRAL VALVE REGURGITATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; TANZANIA;

ASYMPTOMATIC DISEASES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOMEGALY; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIASTOLE; FEMALE; HEART ATRIA; HEART VENTRICLES; HUMANS; MALE; MITRAL VALVE INSUFFICIENCY; STROKE VOLUME; SYSTOLE; TANZANIA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84875195585     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2012.707351     Document Type: Article

References (28)

1. Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007; 49: 311-316.
2. Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 2002; 39: 739-743.
3. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left atrial volume as amorphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am JCardiol. 2002 Dec; 90: 1284-1289.
4. Pritchett AM, Mahoney DW, Jacobsen SJ, Rodeheffer RJ, Karon BL, Redfi eld MM. Diastolic dysfunction and left atrial volume: Apopulation-based study. JAm Coll Cardiol. 2005; 45: 87-92.
5. Piotrowski G, Banach M, Gerdts E, Mikhailidis DP, Hannam S, Gawor R, et al. Left atrial size in hypertension and stroke. JHypertens. 2011; 29: 1988-1993.
6. Moya-Mur JL, Garcia-Martin A, Garcia-Lledo A, Ruiz-Leria S, Jimenez-Nacher JJ, Megias-Sanz A, et al. Indexed left atrial volume is amore sensitive indicator of fi lling pressures and left heart function than is anteroposterior left atrial diameter. Echocardiography. 2010; 27: 1049-1055.
7. Cuspidi CN, F. Sala, C. Valerio, C. Mancia, G. Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: Atissue Doppler study in echocardiographic practice. Blood Press. 2012; 21: 24-30.
8. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am JCardiol. 2001; 87: 320-323.
9. Poulsen MK, Henriksen JE, Dahl J, Johansen A, Gerke O, Vach W, et al. Left ventricular diastolic function in type 2 diabetes mellitus: Prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging. 2010; 3: 24-31.
10. Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, et al. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: Results of DYDA study. Eur JCardiovasc Prev Rehabil. 2011; 18: 415-423.
11. Raev DC. Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type Idiabetic patients. Diabetes Care. 1994; 17: 633-639.
12. Stewart S, Wilkinson D, Hansen C, Vaghela V, Mvungi R, McMurray J, et al. Predominance of heart failure in the Heart of Soweto Study cohort: Emerging challenges for urban African communities. Circulation. 2008; 118: 2360-2367.
13. Lutale JJ, Thordarson H, Abbas ZG, Vetvik K. Microalbuminuria among Type 1 and Type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania. BMC Nephrol. 2007; 8: 2.
14. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). JHypertens. 2007; 25: 1105-1187.
15. Jensen JS, Clausen P, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Detecting microalbuminuria by urinary albumin/creatinine concentration ratio. Nephrol Dial Transplant. 1997; 12: 6-9.
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantifi cation. Eur JEchocardiogr. 2006; 7: 79-108.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy fi ndings. Am JCardiol. 1986; 57: 450-458.
18. de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, et al. Does information on systolic and diastolic function improve prediction of acardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension. 2010; 56: 99-104.
19. Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman D, Lee ET, et al. Prevalence and correlates of mitral regurgitation in apopulation-based sample (the Strong Heart Study). Am JCardiol. 2001; 87: 298-304.
20. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: Anoninvasive technique for evaluation of left ventricular relaxation and estimation of fi lling pressures. JAm Coll Cardiol. 1997; 30: 1527-1533.
21. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfi eld MM, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular fi lling pressures: Acomparative simultaneous Doppler-catheterization study. Circulation. 2000; 102: 1788-1794.
22. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: Anonparametric approach. Biometrics. 1988; 44: 837-845.
23. Gottdiener JS, Reda DJ, Williams DW, Materson BJ. Left atrial size in hypertensive men: Infl uence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. JAm Coll Cardiol. 1997; 29: 651-658.
24. van Heerebeek. L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, et al. Diastolic stiffness of the failing diabetic heart: Importance of fi brosis, advanced glycation end products, and myocyte resting tension. Circulation. 2008; 117: 43-51.
25. Gul K, Celebi AS, Kacmaz F, Ozcan OC, Ustun I, Berker D, et al. Tissue Doppler imaging must be performed to detect early left ventricular dysfunction in patients with type 1 diabetes mellitus. Eur JEchocardiogr. 2009; 10: 841-846.
26. Suys BE, Katier N, Rooman RP, Matthys D, Op De Beeck L, Du Caju MV, et al. Female children and adolescents with type 1 diabetes have more pronounced early echocardiographic signs of diabetic cardiomyopathy. Diabetes Care. 2004; 27: 1947-1953.
27. Sartore G, Piarulli F, Ragazzi E, Burlina S, Chilelli NC, Sarais C, et al. Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: Relationship with glyco-oxidation, lipid-oxidation and antioxidant status. Int JCardiol. 2011 Jun 20. Available from: http://www. ncbi.nlm.nih.gov/pubmed/21696838
28. Fraser GE, Luke R, Thompson S, Smith H, Carter S, Sharpe N. Comparison of echocardiographic variables between type Idiabetics and normal controls. Am JCardiol. 1995; 75: 141-145.